SDZ GLC 756

Known as: GLC 756, GLC-756, SDZ GLC-756 
 

Topic mentions per year

Topic mentions per year

1995-2005
0119952005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Anti-glaucoma drugs exhibiting anti-inflammatory properties are desirable for the long-term treatment of glaucoma since they may… (More)
Is this relevant?
1997
1997
This investigation was designed as a randomized, placebocontrolled, double-masked, crossover study in NZW rabbits with normal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
This investigation was carried out to evaluate the effect of SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, on… (More)
Is this relevant?
1996
1996
SDZ GLC-756, a novel octahydrobenzo[g]quinoline derivative, is equipotent in displacing [3H]SCH23390 from dopamine D1 receptors… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1995
1995
PURPOSE To investigate the intraocular pressure (IOP)-reducing effect and side effects of SDZ GLC-756, a novel dopamine D-1… (More)
Is this relevant?